4/15/2026
Obsidian Therapeutics Goes Public Through Galera Merger, Lands $350 Million to Fuel Cell Therapy Pipeline
A microcap biotech is getting a new identity — and $350 million to go with it.
Galera Therapeutics (OTC: GRTX) and privately-held Obsidian Therapeutics announced today they have entered into a definitive merger agreement to combine in an all-stock transaction. The combined company will operate as Obsidian Therapeutics and plans to trade on Nasdaq under the ticker symbol OBX.
0
3 min read